You are here

Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Meet American College of Rheumatology (ACR) criteria for RA

- Have active RA consisting of ≥ 6 swollen and ≥ 6 painful joints

- ACR functional class I-III

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- At screening the subject's prior medications are reviewed. (Prior history of
disease-modifying antirheumatic drug (DMARD) use is recorded, including the start and
stop dates of the most recently taken DMARDs)

- Significant concurrent medical diseases

- Abnormal chest radiograph, including findings consistent with interstitial
pneumonitis, granulomatous disease, or pleural effusion and/or infiltration

NCT00076206
Pfizer
Terminated
Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Active Rheumatoid Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis
NCT00913458
All Genders
18+
Years
Multiple Sites
Rheumatoid Arthritis
NCT01023100
All Genders
18+
Years
Woburn, Massachusetts
Rheumatoid Arthritis
NCT01558089
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now